Vivek Mittal

@bennyjohnson you are joke

I cannot believe this is happening. Hillary Clinton just STORMED out of the Epstein Deposition because I posted a photo of her testifying. Now the Clinton PR team is crying about me to the press. This is insane. The deposition is being filmed and will be released in full. Hillary wanted it to be done LIVE on TV. Rep. Boebert gave me permission to post a photo she took before the hearing started with credit. Hillary is trying to get out of answering questions about Epstein because of a picture. Does this sound desperate to you?

@Aiims1742 @Perlmutter_CC @nyulangone @JohnPLeonardMD @nyugrossman @NYULangoneLI @NYULangoneBK @DrOscarLahoud @EmelineAvikiMD congrats. great news

I am honored to serve as the new Director of the @Perlmutter_CC. Thanks to Dean/CEO Alec Kimmelman @nyulangone for this opportunity. Excited to partner with @JohnPLeonardMD & the entire PCC community as we build our next exciting chapter. Lots to come! prnewswire.com/news-releases/…

At today’s #CAPITSCMeeting, we were honored to be joined by two patient advocates: Ms. Robin Beth Dubin from @Alive_And_Kickn and Ms. Erica Kirschner from @LFSAssociation. Their powerful stories and perspectives deeply moved us and reinforced the importance of CAP-IT’s mission to discover molecularly and immunologically targeted agents to prevent or intercept cancer in high-risk populations. Dr. Margie Clapper of @FoxChaseCancer, Chair of the Resource Sharing Working Group, shared updates on WG activities, including development of a searchable shared resource catalog with technical assistance from the CAP-IT DRCC team at @RoswellPark. Dr. Yongfeng He @YongfengHe_PhD from @mittallab of @WeillCornell U54 presented updates on their LNP mRNA vaccine project aimed at intercepting the progression from pre-invasive to invasive lung cancer, sparking strong interest and discussion.

The Role of PD-1 in Maintaining Stem-like CD8+ T Cells @Nature ✅PD-1 doesn’t just “brake” — it fine-tunes TCR signaling to prevent exhaustion of precious stem-like CD8+ T cells ✅Blocking PD-1 can depletes these stem-like progenitors 👉PD-1 might be less an off-switch and more a quality controller for long-term T cell immunity nature.com/articles/s4158… @OncoAlert

What if a cancer-causing mutation were less like a ticking time bomb and more like an actor waiting for the right opportunity? Team SPECIFICANCER’s brand new paper gives us an insight. The new paper from SPECIFICANCER, published in @Nature, reveals that it’s not just the mutation that matters — it’s where in the liver that mutation appears. Understanding which cells can turn cancerous — and why — helps us better predict risk and develop smarter, more targeted treatments. Congratulations to the #CancerGrandChallenges SPECIFICANCER team (co-funded by @TheMarkFdn). This work was led by Owen Sansom and Future Leader Alex Raven. 👉 Read more from Alex: lnkd.in/eTVh9YY6 #CancerResearch

@Eman856 @RpsAgainstTrump why

@RpsAgainstTrump Cowards. These people need to be thrown out of office. They should serve the people, not the president.

BREAKING: The Senate blocked a resolution 49–51 that would have forced Trump to get Congress’s approval for military action in Venezuela. Only two Republicans joined Democrats: Rand Paul and Lisa Murkowski.

So gratifying to see state-of-the art cancer research laboratory dedicated to discovering next generation cancer vaccines @CrestTcg . As a founding member and scientific advisor it’s exciting to see this vision come to life shorturl.at/POhmD. shorter.at/HFrtw

@ElizSMcKenna Great Wall is such an amazing experience Enjoy

The warmest welcome to China and then straight to the Great Wall!

We thank the Starr Cancer Consortium, Rory & David Jones, NYSTEM Stem Cell Scholar Training Program, PhRMA Foundation , and NIH (T32 HL134629-Stout-Delgado, TL1-TR-002386 from Weill Cornell CTSC, MCB T32) for their generous support that made this work possible.

The translational part: EZH2 inhibitors like tazemetostat are already FDA-approved for other cancers. Repurposing them for TNBC could provide a rapid path to new anti-metastatic therapies.

Our paper "Epigenetic regulation of CIN in TNBC" is out in Cancer Discovery shorturl.at/EcEfW Fantastic collaboration with @Samuel_Bakhoum @Dow_lab @LabMelnick @LaughneyLab @ElementoLab @WeillCornell @BCRFcure @AmericanCancerS @TNBCFoundation #Chromosomal_Instability